EcoDrugPlus

Utrophin

Ensembl ID : ENSMSIG00000015114
Gene Symbol: UTRN
1 Cross references
266 Possible Orthologues:

V-Raf-Leukemia Viral Oncogene 1

Ensembl ID : ENSMSIG00000000188
Gene Symbol: RAF1
1 Cross references
231 Possible Orthologues:

Vascular Endothelial Growth Factor A

Ensembl ID : ENSMSIG00000012606
Gene Symbol: VEGFA
1 Cross references
268 Possible Orthologues:

Vitamin D (1,25-Dihydroxyvitamin D3) Receptor

Ensembl ID : ENSMSIG00000028053
Gene Symbol: VDR
1 Cross references
473 Possible Orthologues:

Xanthine Dehydrogenase

Ensembl ID : ENSMSIG00000017693
Gene Symbol: XDH
1 Cross references
226 Possible Orthologues:

Ensembl ID : ENSMSIG00000028355
Gene Symbol: -
Cross references: -
400 Possible Orthologues:

Ensembl ID : ENSMSIG00000030338
Gene Symbol: -
Cross references: -
245 Possible Orthologues:

Ensembl ID : ENSMSIG00000030787
Gene Symbol: -
Cross references: -
208 Possible Orthologues:

Ensembl ID : ENSMSIG00000031224
Gene Symbol: -
Cross references: -
338 Possible Orthologues:

Ensembl ID : ENSMSIG00000031421
Gene Symbol: -
Cross references: -
318 Possible Orthologues:

Ensembl ID : ENSMSIG00000031561
Gene Symbol: -
Cross references: -
210 Possible Orthologues:

Ensembl ID : ENSMSIG00000031650
Gene Symbol: -
Cross references: -
239 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).